PHILADELPHIA, Aug. 16 /PRNewswire/ -- Bilcare Limited, a research-based pharmaceutical packaging solutions company, today announced that it has acquired ProClinical, Inc., a Pennsylvania-based pharmaceutical services and packaging company. The acquisition is in line with Bilcare's strategy to expand its global presence, and takes the company closer to achieving its vision of becoming the world leader in the pharmaceutical packaging industry by 2010.
ProClinical Inc. has a U.S. FDA approved facility spread across 14 acres and is Drug Enforcement Agency (DEA) licensed for controlled substances schedule I - V. With a team of 40 professionals, the pharmaceutical services offered by ProClinical are pre/formulation research & development, analytical services including development, clinical batch manufacturing and packaging, distribution of clinical supplies including Interactive Voice Response System, and complete management of controlled drug substances.
Commenting on the acquisition, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare said, "This acquisition is part of Bilcare's overall business strategy to strengthen our footprint in the US. Bilcare has been continuously making efforts to broaden their participation in the pharmaceutical knowledge domain and has taken a significant leap in the value chain, from drug discovery to market, through this acquisition. The transaction provides Bilcare entry into the world's largest pharmaceuticals market through an established organization with an enviable roster of existing clients."
"The acquisition puts Bilcare in the same geographical area as some of the world's largest pharmaceutical companies, some of whom are existing clients of Bilcare in India, putting the company in a position to innovate and adapt quickly and enhancing our ability to add value to our clients."
ProClinical will help Bilcare strengthen and expand its business in the U.S. through the addition of a premium client roster including Johnson & Johnson, AstraZeneca, Bayer, Takeda and Merck, and more than 100 high-growth biotech companies like Genzyme and Progenics among others.
Bilcare, the first Indian packaging company to invest in the U.S., is India's largest pharmaceuticals packaging company and the only company focused on providing packaging solutions solely for the pharmaceutical industry, offering solutions using polymers/plastics, paper and aluminum.
Bilcare is a unique organization with a strong research foundation and an unending quest for global leadership. Bilcare is integrated with global pharmaceuticals requirements and standards, with best-in-class manufacturing and research facilities spread worldwide with a focus on pharmaceutical packaging research. A pioneer in innovative pharmaceutical packaging, Bilcare has operations spread across India, the U.S. and Singapore. Bilcare has a state-of-the-art facility near Pune, India, one of eight such plants in the world and the only one of its kind in Asia.
Winner of the prestigious OPPI award for 2001-02, Bilcare is ISO 9002 and ISO 14001 accredited and has USFDA DMF assigned to its range of films and foils. Its facility in Singapore also was conferred with the prestigious Pioneer Status by the EDB, Government of Singapore.
ProClinical Pharmaceutical Services, Inc. is a privately held company offering formulation development of clinical supplies, analytical testing of materials, drug supply packaging and labeling, and worldwide storage and distribution of clinical materials. It has pioneered the child-resistant, senior-friendly blistercard packaging system known as "Pick and Peel" and offers an interactive voice response system that helps clinical trial managers increase their efficiency in enrolling subjects and managing materials.